COMPANY
Focal Medical, Inc.
Focal Medical is a clinical stage oncology company that has developed an energy-based drug delivery system for local and precise delivery of small molecules with known activity against the targeted tumor type. From company website Source · Oct 12, 2026
NIH awards 7
- NIH contract (government contract; not a grant and not an investment round) 75N91024C00010-0-9999-1 FY2024: $297,965 awarded for that fiscal year; activity N43 (OTHER_NIH); PI HAM, STEPHANIE LEMMO; recipient as written: FOCAL MEDICAL, INC., Cary, NC. 2024 SBIR source ↗
- NIH award 5R44CA224460-05 FY2022: $2,000,000 awarded for that fiscal year; activity R44 (SBIR); PI DAUNCH, WILLIAM ANDREW; recipient as written: FOCAL MEDICAL, INC., Cary, NC. Implantable iontophoresis chemotherapy d source ↗
- NIH award 2R44CA224460-04 FY2021: $2,000,000 awarded for that fiscal year; activity R44 (SBIR); PI DAUNCH, WILLIAM ANDREW; recipient as written: FOCAL MEDICAL, INC., Cary, NC. Implantable iontophoresis chemotherapy d source ↗
- NIH award 5R44CA224460-03 FY2019: $771,376 awarded for that fiscal year; activity R44 (SBIR); PI DAUNCH, WILLIAM ANDREW; recipient as written: FOCAL MEDICAL, INC., Cary, NC. Implantable iontophoresis chemotherapy del source ↗
- NIH award 3R44CA224460-02S1 FY2019: $2,084 awarded for that fiscal year; activity R44 (SBIR); PI DAUNCH, WILLIAM ANDREW; recipient as written: FOCAL MEDICAL, INC., Cary, NC. Implantable iontophoresis chemotherapy del source ↗
- NIH award 4R44CA224460-02 FY2018: $1,111,364 awarded for that fiscal year; activity R44 (SBIR); PI DAUNCH, WILLIAM ANDREW; recipient as written: FOCAL MEDICAL, INC., Cary, NC. Implantable iontophoresis chemotherapy d source ↗
- NIH award 1R44CA224460-01 FY2017: $299,805 awarded for that fiscal year; activity R44 (SBIR); PI DAUNCH, WILLIAM ANDREW; recipient as written: FOCAL MEDICAL, INC., Cary, NC. Implantable iontophoresis chemotherapy del source ↗